Eric Owusu is a Pharmacist with over 20 years of progressive experience in medicines regulation, regulatory leadership, and pharmaceutical quality. He currently serves as the Acting Director of the Drugs and Herbal Medicines Registration Directorate of the Food and Drugs Authority (FDA), Ghana, where he provides strategic leadership in the regulation of medicines and supports the Authority’s mandate to ensure access to quality-assured, safe, and effective medical products.

Eric also leads the FDA Ghana’s digital transformation agenda in regulatory management as Chairperson of the Implementation Committee for the FDA’s Integrated Regulatory Management System (GFIRMS), overseeing initiatives aimed at strengthening regulatory efficiency, transparency, and the use of digital technologies in regulatory processes.

Since 2015, Eric has served as a Consultant to the World Health Organization (WHO) Prequalification Programme and as an External Assessor for the evaluation of pharmaceutical dossiers. He is also a Clinical Fellow of the Federal Institute for Drugs and Medical Devices (BfArM), Germany, where he received specialized training as a Clinical Assessor.

At the regional level, Eric serves as Vice Chairperson of the Technical Working Group for Registration under the West African Health Organization (WAHO) Harmonization Initiative. In this capacity, he contributes to the development, implementation, and harmonization of regional regulatory frameworks and guidelines aimed at strengthening medicines regulation and promoting regulatory convergence across West Africa.

He holds an MSc in Pharmaceutical Quality by Design from De Montfort University, United Kingdom. He has extensive experience in dossier assessment, bioequivalence, pharmaceutical development, regulatory reliance, regulatory convergence, and capacity building, and has delivered numerous technical training programmes and support missions to regulatory authorities across Africa.

Eric is also a member of the Implementation Committee of the Network for WHO Maturity Level 3 National Regulatory Authorities (ML3 NRAs) in Africa, where he contributes to the development of regulatory reliance frameworks designed to enhance collaboration, reduce regulatory duplication, and improve the efficiency of medicines regulatory systems.

With extensive national, regional, and international regulatory experience, Eric is committed to advancing regulatory excellence, strengthening regulatory systems, and promoting harmonized and reliance-based approaches to medicines regulation across Africa, with the ultimate goal of improving equitable access to quality-assured medical products.